News | SPECT-CT | May 05, 2016

Company says ultra-high resolution Discovery NM/CT 670 CZT system can reduce injected dose or scan time by up to 50 percent

GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install

May 5, 2016 — Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose and monitor diseases at a functional level with GE Healthcare’s next-generation SPECT/CT system, Discovery NM/CT 670 CZT. GE claims it is the world’s first general purpose, ultra-high resolution single photon emission computed tomography (SPECT)/CT imaging system, with a new digital detector powered by cadmium zinc telluride (CZT) technology.

SPECT/CT exams are performed to assess the functionality of organs and play a key role in the diagnosis and monitoring of a multitude of diseases. GE Healthcare’s new system is equipped with CZT technology that enables direct conversion of photons into a digital signal, therefore making the technology more efficient. Until now, CZT technology has been limited to organ-dedicated devices, whereas Discovery NM/CT 670 CZT is the first to allow doctors to perform exams on every organ, including whole-body exams.

This technology is intended to help improve clinical efficacy and patient experience. Improved efficacy will allow doctors to detect smaller lesions and quantify them more accurately due to the increased spatial and contrast resolution. This may have a significant role in assessing and monitoring responses to therapies. Having the ability to complete multiple scans in a single visit and reduce the dose injected or the scan time by 50 percent will improve patient experience. Optimizing the duration of the exams or the injected dose represents not only an improvement for the patient experience, but also helps increase the operational and financial efficiency of hospitals.

“We were able to do an in-field upgrade to the Discovery NM/CT 670 CZT, which was a faster and more efficient way to enable us to leverage the new CZT detector. We believe this new system will allow us to see improvements in lesion detectability and will increase the utility of SPECT/CT; we will also look to see how we can reduce scan time, lower dose or both, while maintaining image quality,” said Barry A. Siegel, M.D., professor of radiology and medicine, senior vice-chair and division director of nuclear medicine at Mallinckrodt Institute of Radiology at Washington University in St. Louis. “We look forward to doing research on SPECT/CT quantification, as accurate and reproducible quantification will be increasingly important in nuclear medicine.”

Researchers have identified clinical scenarios where the combination of multiple SPECT tracers could aid physicians in diagnosing and giving much better and more specific reports in difficult patient conditions. However, performing such multi-isotope exams is quite challenging on conventional cameras. Multiple isotope exams could offer a greater insight into the diagnosis and monitoring responses to treatments. With the Discovery NM/CT 670 CZT, clinicians will be able to simultaneously visualize and analyze multiple physiological processes in a patient, gaining insights into multiple dimensions of the patient’s anatomy and physiology at the same time using the hybrid SPECT/CT.

For more information: www.gehealthcare.com

Related Content

News | Nuclear Imaging

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
News | Computed Tomography (CT)

November 28, 2021 — Royal Philips, a leader in health technology, unveiled its vision for interventional medicine by ...

Time November 28, 2021
arrow
News | Nuclear Imaging

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
News | Digital Pathology

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
arrow
News | Coronavirus (COVID-19)

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

Time November 01, 2021
arrow
News | Molecular Imaging

October 29, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time October 29, 2021
arrow
News | Radiation Therapy

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
News | PET Imaging

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
News | PET Imaging

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

Time October 18, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Subscribe Now